Metastatic Castration Resistant Prostate Cancer (mCRPC) patients' experience with Radium-223 treatment in Japan - Supplementary Material
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
Supplementary Table s1: Laboratory parameters Supplementary Table s2: Completion Rate of Ra-223 cycles Supplementary Table s3: Information Questionnaire Supplementary Table s4. Minimally important difference (MID) for PRO scales.
创建时间：
2024-01-26
